The stretches that make people quit, and the measures that mislead
Four failure modes, and the first is load-bearing: the formula's worst stretches are, by its author's own argument, the reason it has survived being published.

Key takeaway
- Multi-year underperformance is not the formula breaking — it is the documented cost that keeps the edge from being competed away
- Reported return on capital flatters companies whose assets are intangible or off the balance sheet, so some 'quality' is an artefact
- The best-documented failure is behavioural: people run the formula and then override its ugliest picks, which is where the returns were
The underperformance is a feature, which does not make it survivable
In the book's own test period the formula trailed the market for stretches measured in years, not months — and Greenblatt presents this as the mechanism that preserves the edge. A published strategy that worked smoothly would attract capital until it stopped working at all. One that periodically humiliates its followers sheds them instead, and the mispricing it feeds on regenerates.
This argument is elegant and it is also a genuine cost. 'The bad years are why it works' is true and consoling in year one of a bad stretch, and nearly impossible to act on in year three. No refinement of the formula shortens the stretch — anything that did would remove the moat.
When return on capital measures the accounting, not the business
Return on capital divides operating profit by recorded operating assets — and 'recorded' is the weak word. A company whose real assets are brands, software or research shows a small capital base, which makes its return on capital enormous. Some of those companies are genuinely great businesses; others are ordinary businesses whose assets the balance sheet cannot see.
- Intangible-heavy companies rank as higher quality than they are, because the capital that built the intangibles was expensed years ago and no longer appears in the denominator.
- Off-balance-sheet obligations cut the other way — a company financing its operations through structures the balance sheet does not carry shows less capital employed than it truly uses.
- One-off spikes in operating profit rank as quality for exactly one year, which is precisely the year the formula buys them.
The basket is the only defence the method offers, and it is a real one: accounting artefacts are scattered across the list rather than systematic, and thirty names absorb them. What the basket cannot absorb is an era in which the artefact becomes systematic — a market whose largest quality businesses are all intangible-heavy is a market where the ranking's idea of quality has quietly drifted.
Threshold implementations fail differently from the book
The product's single-symbol version — ROIC above 15%, EV/EBITDA below 10 — inherits the formula's spirit and a different failure profile. In an expensive market the thresholds pass nothing, so a strategy that was designed never to be out of the market becomes one that can sit in cash for years. In a cheap market they pass nearly everything, and the selectivity the ranking provided is gone.
The best-documented failure is the investor editing the list
Greenblatt later reported a natural experiment from accounts offered through his own firm: clients could either take the formula's picks automatically or approve each purchase themselves. The self-managed accounts ran the same formula and did measurably worse — because given the choice, people skipped the picks that looked most frightening, and the frightening picks were where the returns were concentrated.
A stock reaches the top of the combined list by being cheap, and stocks are rarely cheap while the news about them is good. Every name the formula hands you arrives with a plausible reason not to buy it. Vetoing those names feels like prudence and is, on the recorded evidence, the single most reliable way to underperform your own system.
Common questions
- How long is a fair trial for the formula?
- Longer than feels reasonable. The documented bad stretches run multiple years, so a trial shorter than that cannot distinguish the formula failing from the formula doing what its own book says it does. Five years is a minimum honest window; anyone unwilling to commit to that timeframe in advance should not start.
- Has publication killed the edge?
- The returns since the book are visibly less dramatic than the backtest that made it famous, which is the normal fate of published results — part decay, part the backtest flattering itself. The behavioural argument for why some edge persists is credible but unfalsifiable in advance. Run it expecting the modest version, not the book's, and the decision still has to survive that arithmetic.
- Can I fix the ROIC problem by adjusting for intangibles?
- Analysts do — capitalising research spending, adding back goodwill — and each adjustment is a judgement call that reintroduces exactly the discretion the formula exists to remove. A consistently applied imperfect measure ranks a universe more honestly than a hand-adjusted better one, because hand adjustment never gets applied evenly across three thousand companies.
These are documented methods described for study. Nothing here is investment advice, a recommendation, or a claim about future returns — every system on this page has losing periods, and the pages say where.
Reading about a system is not having one.
Plutux is where you write your own rules down, test them against real data, and keep the record your memory would otherwise rewrite. Join the waitlist for early access.